Glaukos (NYSE:GKOS) Upgraded by Mizuho to Outperform Rating
Glaukos (NYSE:GKOS – Get Free Report) was upgraded by research analysts at Mizuho from a “neutral” rating to an “outperform” rating in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The brokerage presently has a $200.00 price target on the medical instruments supplier’s stock, up from their previous price target of $140.00. […]
Glaukos (NYSE:GKOS – Get Free Report) was upgraded by research analysts at Mizuho from a “neutral” rating to an “outperform” rating in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The brokerage presently has a $200.00 price target on the medical instruments supplier’s stock, up from their previous price target of $140.00. […]
